Article: P2.03 Belgian Stop IMatinib trial

Related products

• 

  Article: Highlights in melanoma

  €2.42 Add to cart
• 

  Article: Highlights in squamous cell carcinoma of the head and neck

  €2.42 Add to cart
• 

  Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

  €2.42 Add to cart
• 

  Article: Highlights in respiratory oncology

  €2.42 Add to cart